您的位置: 首页 > 2020年1月 第51卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

总额控制下的病种分值付费和单病种付费支付方式比较

Comparison of the method of paying for the value of the disease under the total amount and the payment method of the single disease

来源期刊: 广州医药 | 78-81 发布时间:2021-11-28 收稿时间:2025/11/13 17:58:44 阅读量:12
作者:
关键词:
总额控制病种分值付费单病种付费
Total controlDisease type value paymentSingle disease payment
DOI:
10.3969/j.issn.1000-8535.2020.01.018
收稿时间:
2019-06-06 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 分析比较总额控制下的病种分值付费和单病种付费支付方式的应用效果。方法 回顾性分析2015年—2018年总额控制下病种分值付费和单病种付费模式下的平均住院费用、医保基金支出以及医保基金收入等基本情况,比对分析总额控制下单病种付费模式下与病种分值付费模式的总体运行效率。结果 2015年—2018年总额控制下病种分值付费情况存在轻微波动,但不出现明显上涨现象,稳定于9 000元左右的水平,并且总额控制下病种分值付费的医保基金结余率处于17%的水平,同时具有稳定的医保基金支出与医保基金收入水平。相比较总额控制下病种分值付费,单病种付费模式下的平均住院费用更高,且呈现出逐年增加的发展趋势;相比较2015年的平均住院费用,2018年平均住院费用高出500元。2015年—2018年总额控制下单病种付费的医保基金结余率具有较大波动,表示医保基金支出与医保基金收入水平不稳定。结论 总额控制下的病种分值付费模式具有明显的医疗费用以及医保基金费用支出控制效果,但同时也具有较大的基础投入水平以及较高管理成本等缺陷端,总额控制下的单病种付费模式具有方便管理的优势,但是在费用控制、病种涵盖等方面不如病种分值付费,总额控制下的单病种付费与病种分值付费各具优势和不足,需要依据区域情况,取长补短,因地制宜以及择优而用,确保健全医保支付方式。
Objective To analyze the application effect of the payment of disease type and the payment of single disease payment under the control of total amount. Methods A retrospective analysis of the basic hospitalization expenses, medical insurance fund expenditures and medical insurance fund income under the control of the total value of the disease and the single-income payment model under the total control from 2015 to 2018 were taken, and to have comparative analysis of the total control of the single disease overall operational efficiency of the payment model with the payment model. Results There was a slight fluctuation in the payment of disease value under the control of total amount from 2015 to 2018, but there was no obvious increase, which was stable at around 9 000 yuan, and the balance of medical insurance fund paid for the disease value under the total control was at 17% level and has both stable medical insurance fund expenditure and medical insurance fund income level. Compared with the total score control under the total amount control, the average hospitalization cost under the single disease payment mode was higher, and showed a trend of increasing year by year; compared with the average hospitalization cost in 2015, the average hospitalization cost in 2018 was higher, out of 500 yuan. From 2015 to 2018, the balance of the medical insurance fund paid for the control of the single disease had a large fluctuation, indicating that the medical insurance fund expenditure and the medical insurance fund income level were unstable. Conclusion The disease-based payment model under total control has obvious control effect of medical expenses and medical insurance fund expenses, but it also has a large basic input level and high management cost and other defects. The payment model has the advantage of convenient management, but it is not as good as the cost control and disease coverage, and the single disease payment and the disease value payment under the total control have their own advantages and disadvantages, which need to be based on the regional situation. We need to make use of the strengths and weaknesses, adapt to local conditions and choose the best, to ensure a sound medical insurance payment method.
1、 沈掩瑜,赵明.总额控制下的按病种分值付费医院控费策略探讨[J]. 江苏卫生事业管理,2018,29(11):1288-1290. 沈掩瑜,赵明.总额控制下的按病种分值付费医院控费策略探讨[J]. 江苏卫生事业管理,2018,29(11):1288-1290.
2、 刘童.东营市按病种分值结算办法的实践与思考[J]. 中国医疗保险,2017,10(1):31-33. 刘童.东营市按病种分值结算办法的实践与思考[J]. 中国医疗保险,2017,10(1):31-33.
3、 李少玲.按病种分值付费对医院病案管理工作的影响及对策[J]. 中国当代医药,2018,11(12):128-130. 李少玲.按病种分值付费对医院病案管理工作的影响及对策[J]. 中国当代医药,2018,11(12):128-130.
4、 邓倩,李东华,肖黎,等. 我国基本医疗保险总额控制下的按病种分值付费现状研究[J]. 医学与社会,2016,29(9):11-13. 邓倩,李东华,肖黎,等. 我国基本医疗保险总额控制下的按病种分值付费现状研究[J]. 医学与社会,2016,29(9):11-13.
5、 徐伟,郝梅,杜珍珍.总额控制下按病种分值付费的实践与思考[J]. 中国药房,2016,21(6):721-723. 徐伟,郝梅,杜珍珍.总额控制下按病种分值付费的实践与思考[J]. 中国药房,2016,21(6):721-723.
6、 洪流.总额控制下的病种分值付费和单病种付费支付方式对比[J]. 中国卫生产业,2017,14(4):15-16. 洪流.总额控制下的病种分值付费和单病种付费支付方式对比[J]. 中国卫生产业,2017,14(4):15-16.
7、 张鹏.黑龙江省基本医疗保险支付方式试点医院改革研究[D]. 黑龙江大学,2017. 张鹏.黑龙江省基本医疗保险支付方式试点医院改革研究[D]. 黑龙江大学,2017.
8、 侯潇潇.医保按病种分值付费对医院管理的影响及对策[J]. 财经界(学术版),2018,495(21):34-35. 侯潇潇.医保按病种分值付费对医院管理的影响及对策[J]. 财经界(学术版),2018,495(21):34-35.
9、 陶春莲,卢锡芝,张浩群,等. 按病种分值结算的实施效果分析-以某三甲医院为例[J]. 中国医疗保险,2018,119(08):58-62. 陶春莲,卢锡芝,张浩群,等. 按病种分值结算的实施效果分析-以某三甲医院为例[J]. 中国医疗保险,2018,119(08):58-62.
10、 DAMBSKA M, LABRADOR E B, KUO C L, et al. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control[J]. Pediatr Diabetes, 2017, 18(5):327-331. DAMBSKA M, LABRADOR E B, KUO C L, et al. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control[J]. Pediatr Diabetes, 2017, 18(5):327-331.
11、 郭晓峰,赵玲.东营市医保按病种分值结算办法运行分析及对策研究[J]. 中国医疗保险,2018,116(05):49-51. 郭晓峰,赵玲.东营市医保按病种分值结算办法运行分析及对策研究[J]. 中国医疗保险,2018,116(05):49-51.
12、 解达,翟素娟,姜丽等. 江苏淮安按病种分值结算支付方式下医院控费实践[J]. 中华医院管理杂志,2017,33(4):278. 解达,翟素娟,姜丽等. 江苏淮安按病种分值结算支付方式下医院控费实践[J]. 中华医院管理杂志,2017,33(4):278.
13、 王克杰,韩关臣.东营市医保双控下按病种分值结算办法研究[J]. 山东人力资源和社会保障,2018,353(10):34-36. 王克杰,韩关臣.东营市医保双控下按病种分值结算办法研究[J]. 山东人力资源和社会保障,2018,353(10):34-36.
14、 TIROSH A, PAPADAKIS G Z, MILLO C, et al. Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total Ga-DOTATATE-Avid tumor volume measurements[J]. Eur J Endocrinol, 2017, 176(5):575-582. TIROSH A, PAPADAKIS G Z, MILLO C, et al. Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total Ga-DOTATATE-Avid tumor volume measurements[J]. Eur J Endocrinol, 2017, 176(5):575-582.
15、 陈曼莉,赵斌.实行按病种分值付费制度的实践经验及启示[J]. 中国卫生经济,2017,36(6):38-41. 陈曼莉,赵斌.实行按病种分值付费制度的实践经验及启示[J]. 中国卫生经济,2017,36(6):38-41.
16、 解满平,姜丽,翟素娟,等. 江苏淮安按病种分值结算支付方式下医院控费实践[J]. 中华医院管理杂志,2017,33(4):278. 解满平,姜丽,翟素娟,等. 江苏淮安按病种分值结算支付方式下医院控费实践[J]. 中华医院管理杂志,2017,33(4):278.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录